Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina)
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether addition of bemiparin, once daily in
icodextrin solution for peritoneal dialysis for 16 weeks, increases the peritoneal capacity
for ultrafiltration and/or reduces creatinine transport in peritoneal dialysis patients
presenting functional disorders related to ultrafiltration deficit and/or high transport.